Who
Joshua F. Patterson
Officer
Company insider
Files Form 4 as: Officer, CG Oncology; General Counsel, Gamida Cell; General Counsel, Akcea Therapeutics.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $13K
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 19 Mar 2020
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,266 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,266 at $0.00 | filing |
| 15 Apr 2025filed 16 Apr 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —119,922 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,775 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 31 Jan 2024filed 2 Feb 2024 | Gamida Cell | SEC FORM 4 Code A | —480,319 at $0.00 | filing |
| 8 Feb 2023filed 10 Feb 2023 | Gamida Celloption or derivative | SEC FORM 4 Code A | —125,860 at $0.00 | filing |
| 8 Feb 2023filed 10 Feb 2023 | Gamida Cell | SEC FORM 4 Code A | —63,000 at $0.00 | filing |
| 28 Jan 2022filed 1 Feb 2022 | Gamida Celloption or derivative | SEC FORM 4 Code A | —77,900 at $0.00 | filing |
| 28 Jan 2022filed 1 Feb 2022 | Gamida Cell | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 12 Oct 2020filed 13 Oct 2020 | Akcea Therapeuticsoption or derivative | SEC FORM 4 Code D | $16K13,750 at $1.16 | filing |
| 12 Oct 2020filed 13 Oct 2020 | Akcea Therapeuticsoption or derivative | SEC FORM 4 Code D | $40K7,500 at $5.39 | filing |
| 12 Oct 2020filed 13 Oct 2020 | Akcea Therapeutics | SEC FORM 4 Code U | $482K26,532 at $18.15 | filing |
| 22 Sep 2020filed 24 Sep 2020 | Akcea Therapeutics | SEC FORM 4 Sold | $5,780319 at $18.12 | filing |
| 17 Jul 2020filed 20 Jul 2020 | Akcea Therapeutics | SEC FORM 4 Sold | $3,288263 at $12.50 | filing |
| 15 Apr 2020filed 15 Apr 2020 | Akcea Therapeutics | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 23 Mar 2020filed 25 Mar 2020 | Akcea Therapeutics | SEC FORM 4 Sold | $3,940335 at $11.76 | filing |
| 19 Mar 2020filed 23 Mar 2020 | Akcea Therapeuticsoption or derivative | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 19 Mar 2020filed 23 Mar 2020 | Akcea Therapeutics | SEC FORM 4 Code A | —3,780 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.